{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:16:57Z","timestamp":1778869017027,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11095-025-04003-1","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:07:18Z","timestamp":1775671638000},"page":"1291-1304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Innovative Multifaceted Approach to Enhance the Sensitivity of a Target Engagement ELISA"],"prefix":"10.1007","volume":"43","author":[{"given":"Nahong","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Beley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Maiolica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Cunliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"De Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"4003_CR1","doi-asserted-by":"publisher","unstructured":"Zheng S, McIntosh T, Wang W. Utility of free and total target measurements as target engagement and efficacy biomarkers in biotherapeutic development--opportunities and challenges. J Clin Pharmacol. 2015;55. https:\/\/doi.org\/10.1002\/jcph.357.","DOI":"10.1002\/jcph.357"},{"issue":"1","key":"4003_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1208\/s12248-013-9545-8","volume":"16","author":"W Wang","year":"2014","unstructured":"Wang W, Wang X, Doddareddy R, Fink D, Mclntosh T, Davis HM, Zhou H. Mechanistic pharmacokinetic\/ target engagement\/pharmacodynamic (PK\/TE\/PD) modeling in deciphering interplay between a monoclonal antibody and its soluble target in cynomolgus monkeys. AAPS J. 2014;16(1):129\u201339. https:\/\/doi.org\/10.1208\/s12248-013-9545-8.","journal-title":"AAPS J"},{"issue":"1","key":"4003_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1208\/s12248-011-9251-3","volume":"13","author":"JW Lee","year":"2011","unstructured":"Lee JW, Kelley M, King LE, Yang J, Salimi-Moosavi H, Tang MT, Lu JF, Kamerud J, Ahene A, Myler H, Rogers C. Bioanalytical approaches to quantify \u201ctotal\u201d and \u201cfree\u201d therapeutic antibodies and their targets: technical challenges and PK\/PD applications over the course of drug development. AAPS J. 2011;13(1):99\u2013110. https:\/\/doi.org\/10.1208\/s12248-011-9251-3.","journal-title":"AAPS J"},{"issue":"20","key":"4003_CR4","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.4155\/bio.12.220","volume":"4","author":"JW Lee","year":"2012","unstructured":"Lee JW, Salimi-Moosavi H. Bioanalysis of target biomarker and PK\/PD relevancy during the development of biotherapeutics. Bioanalysis. 2012;4(20):2513\u201323. https:\/\/doi.org\/10.4155\/bio.12.220.","journal-title":"Bioanalysis"},{"issue":"5","key":"4003_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/clpt.2008.170","volume":"84","author":"W Wang","year":"2008","unstructured":"Wang W, Wang EQ, Balthasar JP. Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 2008;84(5):548\u201358. https:\/\/doi.org\/10.1038\/clpt.2008.170.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"4003_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1517\/17425255.2012.643868","volume":"8","author":"R Deng","year":"2012","unstructured":"Deng R, Jin F, Prabhu S, Iyer S. Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development. Expert Opin Drug Metab Toxicol. 2012;8(2):141\u201360. https:\/\/doi.org\/10.1517\/17425255.2012.643868.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"4003_CR7","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1002\/jps.23330","volume":"101","author":"L Zhao","year":"2012","unstructured":"Zhao L, Shang EY, Sahajwalla CG. Application of pharmacokinetics- pharmacodynamics\/clinical response modeling and simulation for biologics drug development. J Pharm Sci. 2012;101(12):4367\u201382. https:\/\/doi.org\/10.1002\/jps.23330.","journal-title":"J Pharm Sci"},{"issue":"2","key":"4003_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11095-008-9739-4","volume":"26","author":"Y Vugmeyster","year":"2009","unstructured":"Vugmeyster Y, Tian X, Szklut P, Kasaian M, Xu X. Pharmacokinetic and pharmacodynamic modeling of a humanized anti-IL-13 antibody in naive and Ascaris-challenged cynomolgus monkeys. Pharm Res. 2009;26(2):306\u201315. https:\/\/doi.org\/10.1007\/s11095-008-9739-4.","journal-title":"Pharm Res"},{"issue":"5","key":"4003_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1084\/jem.20082481","volume":"206","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Lowe P, Felix SD, Rordorf C, Leslie K, Madhoo S, Wittkowski H, Bek S, Hartmann N, Bosset S, Hawkins PN, Jung T. In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes. J Exp Med. 2009;206(5):1029\u201336. https:\/\/doi.org\/10.1084\/jem.20082481.","journal-title":"J Exp Med"},{"key":"4003_CR10","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1038\/psp.2012.6","volume":"1","author":"S Ait-Oudhia","year":"2012","unstructured":"Ait-Oudhia S, Lowe PJ, Mager DE. Bridging clinical outcomes of canakinumab treatment in patients with rheumatoid arthritis with a population model of IL-1beta kinetics. CPT: Pharm Syst Pharmacol. 2012;1:e5. https:\/\/doi.org\/10.1038\/psp.2012.6.","journal-title":"CPT: Pharm Syst Pharmacol"},{"key":"4003_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.peptides.2015.04.012","volume":"72","author":"S Aydin","year":"2015","unstructured":"Aydin S. A short history, principles, and types of ELISA, and our laboratory experience with peptide\/protein analyses using ELISA. Peptides. 2015;72:4\u201315. https:\/\/doi.org\/10.1016\/j.peptides.2015.04.012.","journal-title":"Peptides"},{"key":"4003_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0009-8981(73)90211-8","volume":"48","author":"L Belanger","year":"1973","unstructured":"Belanger L, Sylvestre C, Dufour D. Enzyme-linked immunoassay for alpha-fetoprotein by competitive and sandwich procedures. Clin Chim Acta. 1973;48:15\u20138. https:\/\/doi.org\/10.1016\/0009-8981(73)90211-8.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"4003_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0019-2791(71)90454-x","volume":"8","author":"E Engvall","year":"1971","unstructured":"Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G Immunochemistry. 1971;8(9):871\u20134. https:\/\/doi.org\/10.1016\/0019-2791(71)90454-x.","journal-title":"Immunochemistry"},{"issue":"2","key":"4003_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1373\/clinchem.2009.127803","volume":"56","author":"E Engvall","year":"2010","unstructured":"Engvall E. The ELISA, Enzyme-Linked Immunosorbent Assay. Clin Chem. 2010;56(2):319\u201320. https:\/\/doi.org\/10.1373\/clinchem.2009.127803.","journal-title":"Clin Chem"},{"issue":"1","key":"4003_CR15","first-page":"55","volume":"53","author":"A Voller","year":"1976","unstructured":"Voller A, Bidwell DE, Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ. 1976;53(1):55\u201365.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"4003_CR16","first-page":"732","volume":"23","author":"GE Kenny","year":"1987","unstructured":"Kenny GE, Dunsmoor CL. Effectiveness of detergents in blocking nonspecific binding of IgG in the enzyme-linked immunosorbent assay (ELISA) depends upon the type of polystyrene used. J Med Sci. 1987;23(6):732\u20134.","journal-title":"J Med Sci"},{"key":"4003_CR17","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1038\/s41467-022-32796-x","volume":"13","author":"AA Hariri","year":"2022","unstructured":"Hariri AA, Newman SS, Tan S, Mamerow D, Adams AM, Maganzini N, Zhong BL, Dunn AR, Soh HT. Improved immunoassay sensitivity and specificity using single-molecule colocalization. Nat Commun. 2022;13:5359. https:\/\/doi.org\/10.1038\/s41467-022-32796-x.","journal-title":"Nat Commun"},{"issue":"1","key":"4003_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ab.2009.09.032","volume":"397","author":"P Spies","year":"2010","unstructured":"Spies P, Mueller R, Chen GJ, Gygax D. A simple approach to improve the sensitivity of enzyme-linked immunosorbent assay: using the IMAPlate 5RC96 for result readout. Anal Biochem. 2010;397(1):48\u201352. https:\/\/doi.org\/10.1016\/j.ab.2009.09.032.","journal-title":"Anal Biochem"},{"issue":"13","key":"4003_CR19","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1021\/ac800352j","volume":"80","author":"T Matsunaga","year":"2008","unstructured":"Matsunaga T, Hosokawa M, Arakaki A, Taguchi T, Mori T, Tanaka T, Takeyama H. High-efficiency single-cell entrapment and fluorescence in situ hybridization analysis using a poly(dimethylsiloxane) microfluidic device integrated with a black poly (ethylene terephthalate) micromesh. Anal Chem. 2008;80(13):5139\u201345. https:\/\/doi.org\/10.1021\/ac800352j.","journal-title":"Anal Chem"},{"key":"4003_CR20","doi-asserted-by":"publisher","unstructured":"Hayrapetyan H, Tran T, Tellez-Corrales E, Madiraju C. Enzyme-Linked Immunosorbent Assay: Types and Applications. In: Matson RS (ed) ELISA. Methods in Molecular Biology. 2023;2612:1\u201317. Humana, New York, NY.https:\/\/doi.org\/10.1007\/978-1-0716-2903-1_1.","DOI":"10.1007\/978-1-0716-2903-1_1"},{"issue":"3","key":"4003_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4155\/bio.11.312","volume":"4","author":"JH Sloan","year":"2012","unstructured":"Sloan JH, Ackermann BL, Carpenter JW, Nguyen HT, Stopa K, Siegel RW, Konrad RJ. A novel, high sensitivity and drug-tolerant sandwich immunoassay for the quantitative measurement of circulating proteins. Bioanalysis. 2012;4(3):241\u20138. https:\/\/doi.org\/10.4155\/bio.11.312.","journal-title":"Bioanalysis"},{"key":"4003_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2533\/chimia.2010.789","volume":"64","author":"MA Sciotti","year":"2010","unstructured":"Sciotti MA, Chen GJ, Gygax D. IMAPlate based miniature, high sensitive, rapid screening method for detecting bioengineered, secreted lipase activities in yeast expression systems. Chimia. 2010;64:789\u201392. https:\/\/doi.org\/10.2533\/chimia.2010.789.","journal-title":"Chimia"},{"issue":"5","key":"4003_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1155\/2013\/290670","volume":"35","author":"J Doucet","year":"2013","unstructured":"Doucet J, Zhao A, Fu J, Avrameas A. Development and validation of an ELISA at acidic pH for the quantitative determination of IL-13 in human plasma and serum. Dis Markers. 2013;35(5):465\u201374. https:\/\/doi.org\/10.1155\/2013\/290670.","journal-title":"Dis Markers"},{"issue":"12","key":"4003_CR24","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.4049\/jimmunol.0901028","volume":"183","author":"W Chen","year":"2009","unstructured":"Chen W, Sivaprasad U, Tabata Y, Gibson AM, Stier MT, Finkelman FD, Hershey GKK. IL-13 Receptor alpha 2 membrane and soluble isoforms differ in human and mouse. J Immuno. 2009;183(12):7870. https:\/\/doi.org\/10.4049\/jimmunol.0901028.","journal-title":"J Immuno"},{"issue":"4","key":"4003_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1365-2222.2007.02921.x","volume":"38","author":"M O\u2019Toole","year":"2008","unstructured":"O\u2019Toole M, Legault H, Ramsey R, Wynn TA, Kasaian MT. A novel and sensitive ELISA reveals that the soluble form of IL-13R-\u03b12 is not expressed in plasma of healthy or asthmatic subjects. Clin Exp Allergy. 2008;38(4):594\u2013601. https:\/\/doi.org\/10.1111\/j.1365-2222.2007.02921.x.","journal-title":"Clin Exp Allergy"},{"key":"4003_CR26","doi-asserted-by":"publisher","unstructured":"Durham TB, Wiley MR. Target engagement measures in preclinical drug discovery: theory, methods, and case studies. Translating molecules into medicines. Volume 25. 2017. https:\/\/doi.org\/10.1007\/978-3-319-50042-3_3.","DOI":"10.1007\/978-3-319-50042-3_3"},{"key":"4003_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.rmed.2019.06.024","volume":"154","author":"D Dimitrova","year":"2019","unstructured":"Dimitrova D, Youroukova V, Ivanova-Todorova E, Tumangelova-Yuzeir K, Velikova T. Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma. Respir Med. 2019;154:144\u201354. https:\/\/doi.org\/10.1016\/j.rmed.2019.06.024.","journal-title":"Respir Med"},{"key":"4003_CR28","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41598-023-31078-w","volume":"13","author":"K Gotfredsen","year":"2023","unstructured":"Gotfredsen K, Liisborg C, Skov V, Kj\u00e6r L, Hasselbalch HC, S\u00f8rensen TL. Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms. Nature. 2023;13:4077. https:\/\/doi.org\/10.1038\/s41598-023-31078-w.","journal-title":"Nature"},{"issue":"4","key":"4003_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4155\/bio.15.254","volume":"8","author":"F Cai","year":"2016","unstructured":"Cai F, Hornauer H, Peng K, Schofield CA, Scheerens H, Morimoto AM. Bioanalytical challenges and improved detection of circulating levels of IL-13. Bioanalysis. 2016;8(4):323\u201332. https:\/\/doi.org\/10.4155\/bio.15.254.","journal-title":"Bioanalysis"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-04003-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-04003-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-04003-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:54:03Z","timestamp":1778867643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-04003-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4003"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-04003-1","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nahong Qiu is one of the founders of NCL New Concept Lab GmbH that commercializes IMAPlate\u2122 technology. All authors are employees of Novartis and have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}